Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
960.37%
129.68%
63.24%
43.15%
33.45%
26.51%
Gross Margin
-549.22%
-549.22%
-549.22%
-549.22%
-549.22%
-549.22%
Sector average
16.85%
17.71%
17.71%
17.71%
17.71%
17.71%
Total Assets
SEK 8,262.00K
SEK 6,075.25K
SEK 7,105.68K
SEK 8,104.65K
SEK 9,143.13K
SEK 9,734.71K
Sector average
SEK 2,857,190.78K
SEK 2,900,240.60K
SEK 3,045,009.79K
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Enorama Pharma AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
Net Income
-SEK 75,139.00K
-SEK 86,485.78K
-SEK 101,678.46K
-SEK 116,426.49K
-SEK 131,773.20K
-SEK 140,522.78K
Sector average
-SEK 2,851.32K
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
Valuation
SEK 142,464.38K
SEK 163,978.00K
SEK 192,783.49K
SEK 220,745.92K
SEK 249,843.44K
SEK 266,432.75K
Sector average
SEK 3,960,502.41K
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
Stock Price
SEK 1.91
SEK 2.20
SEK 2.58
SEK 2.96
SEK 3.35
SEK 3.57
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
Enorama Pharma AB (publ) (ERMA.ST) Financial Forecast | Equlion
